Adial Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $ | $0 |
Gross Profit | ||||
EBITDA | -1,882 | -2,267 | -1,940 | -2,211 |
EBIT | -1,882 | -2,267 | -1,940 | -2,211 |
Net Income | -1,958 | -2,228 | -2,070 | -2,191 |
Net Change In Cash | 0 | 0 | 0 | |
Free Cash Flow | -1,749 | -1,585 | -1,453 | -1,694 |
Cash | 5,914 | 2,365 | 3,750 | 5,204 |
Basic Shares | 10,622 | 18,588 | 18,588 | 5,835 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -60 | -55 | ||
EBITDA | -13,196 | -7,001 | -10,273 | -19,462 |
EBIT | -13,197 | -7,001 | -10,274 | -19,517 |
Net Income | -13,197 | -7,001 | -12,731 | -19,423 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,922 | -6,806 | -11,185 | -12,014 |
Cash | 3,750 | 2,827 | 4,001 | 6,062 |
Basic Shares | 18,588 | 1,424 | 1,063 | 743 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.18 |
2025-03-31 | -$0.34 |
2024-12-31 | -$0.15 |
2024-09-30 | -$0.38 |
